Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Liabilities from Discontinued Operations (2016)

Lisata Therapeutics filings provide 3 years of Liabilities from Discontinued Operations readings, the most recent being 5791134.0 for Q4 2016.

For the quarter ending Q4 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 5791134.0, compared with a TTM value of 5791134.0 through Dec 2016, changed N/A, and an annual FY2016 reading of 5791134.0, changed N/A over the prior year.
Liabilities from Discontinued Operations hit 5791134.0 in Q4 2016 for Lisata Therapeutics, down from 39343867.0 in the prior quarter.
The five-year high for Liabilities from Discontinued Operations was 39343867.0 in Q3 2012, with the low at 5791134.0 in Q4 2016.